Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Morgan Stanley has upgraded Cencora and raised price targets for its rivals, McKesson and Cardinal Health, citing a "golden era" for drug distributors. The analyst, Erin Wright, believes that the industry deserves a premium valuation due to favorable market conditions. Cencora was specifically upgraded, with Wright highlighting the company's strong performance and growth potential.
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios